Tumor cells hijack the PD-1/PD-L1 interaction from the immune system to suppress the antitumor T-cell responses through PD-L1 expression, thereby escaping from immunosurveillance (Ciciola et al., 2020). The gene discussed is CD274; the disease is neoplasm.